Risk stratification of pT1-3N0 patients after radical cystectomy for adjuvant chemotherapy counselling (Q36419132)

14 August 2017

Risk stratification of pT1-3N0 patients after radical cystectomy for adjuvant chemotherapy counselling (English)

1 reference

14 August 2017

1 reference

0 references

10

S Daneshmand

1 reference

14 August 2017

E Xylinas

1

1 reference

14 August 2017

E K Cha

2

1 reference

14 August 2017

M Sun

3

1 reference

14 August 2017

M Rink

4

1 reference

14 August 2017

Q-D Trinh

5

1 reference

14 August 2017

G Novara

6

1 reference

14 August 2017

D A Green

7

1 reference

14 August 2017

A Pycha

8

1 reference

14 August 2017

Y Fradet

9

1 reference

14 August 2017

R S Svatek

11

1 reference

14 August 2017

H-M Fritsche

12

1 reference

14 August 2017

W Kassouf

13

1 reference

14 August 2017

D S Scherr

14

1 reference

14 August 2017

T Faison

15

1 reference

14 August 2017

J J Crivelli

16

1 reference

14 August 2017

S T Tagawa

17

1 reference

14 August 2017

M Zerbib

18

1 reference

14 August 2017

P I Karakiewicz

19

1 reference

14 August 2017

S F Shariat

20

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 November 2012

1 reference

British Journal of Cancer

14 August 2017

1 reference

14 August 2017

107

1 reference

14 August 2017

11

1 reference

14 August 2017

1826-1832

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.2012.464

14 August 2017

0 references

cites work

Current status of molecular markers for prognostication and outcome in invasive bladder cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504939

External validation of postoperative nomograms for prediction of all-cause mortality, cancer-specific mortality, and recurrence in patients with urothelial carcinoma of the bladder

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504939

Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504939

Critical review of prostate cancer predictive tools

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504939

Clinical benefits of a multivariate prediction model for bladder cancer: a decision analytic approach

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504939

An updated catalog of prostate cancer predictive tools

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504939

Comparison of nomograms with other methods for predicting outcomes in prostate cancer: a critical analysis of the literature

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504939

Nomograms for bladder cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504939

Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504939

Adjuvant chemotherapy in invasive bladder cancer: a systematic review and meta-analysis of individual patient data Advanced Bladder Cancer (ABC) Meta-analysis Collaboration

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504939

Prediction of cumulative incidence function under the proportional hazards model

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504939

Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504939

Evaluating the yield of medical tests

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504939

Predicting individual outcomes after radical cystectomy: an external validation of current nomograms

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504939

Radical cystectomy for urothelial carcinoma of the bladder without neoadjuvant or adjuvant therapy: long-term results in 1100 patients.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504939

Use of neoadjuvant chemotherapy for muscle-invasive bladder cancer is low among major European centres: results of a feasibility questionnaire

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504939

Development of a new outcome prediction model in carcinoma invading the bladder based on preoperative serum C-reactive protein and standard pathological risk factors: the TNR-C score

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504939

International validation of the prognostic value of lymphovascular invasion in patients treated with radical cystectomy

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504939

Multiple biomarkers improve prediction of bladder cancer recurrence and mortality in patients undergoing cystectomy

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504939

Nomograms provide improved accuracy for predicting survival after radical cystectomy.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504939

Precystectomy nomogram for prediction of advanced bladder cancer stage.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504939

Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504939

Conditional survival of patients with the four major histologic subgroups of lung cancer in Denmark.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504939

Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504939

A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3504939

Evaluating the yield of medical tests

21 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FBJC.2012.464

Risk stratification of organ confined bladder cancer after radical cystectomy using cell cycle related biomarkers

21 January 2018

1 reference

12 December 2020

Death certificates are valid for the determination of cause of death in patients with upper and lower tract urothelial carcinoma

1 reference

12 December 2020

Postoperative nomogram predicting risk of recurrence after radical cystectomy for bladder cancer

1 reference

12 December 2020

Nomogram for predicting disease recurrence after radical cystectomy for transitional cell carcinoma of the bladder

1 reference

12 December 2020

Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium

1 reference

12 December 2020

Soft tissue surgical margin status is a powerful predictor of outcomes after radical cystectomy: a multicenter study of more than 4,400 patients

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.2012.464

1 reference

14 August 2017

1 reference

14 August 2017

PubMed publication ID

23169335

1 reference